We are still in a bull market, and overall sentiment remains strongly bullish.
All that’s needed now is news of FDA approval for LUNGFIT-2, along with updates on advancement studies from the Beyond Cancer subsidiary. There is far more to this company than many realize.
We are still in a bull market, and overall sentiment remains strongly bullish.
All that’s needed now is news of FDA approval for LUNGFIT-2, along with updates on advancement studies from the Beyond Cancer subsidiary. There is far more to this company than many realize.
That’s the real catalyst behind today’s surge.
The next question is: where does it go from here?
Insider ownership stands at approximately 61–62%, which is a strong vote of confidence.
No comments:
Post a Comment